ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Gaumont Sa

Gaumont Sa (0EJB)

135.50
0.00
(0.00%)
마감 23 1월 1:30AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
135.50
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
135.50 52주 범위 135.50
market_cap
전일 종가
135.50
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
0.00
발행 주식
3,120,000
배당수익률
-
주가수익률
-70.32
주당순이익(EPS)
-1.18
매출
221.71M
순이익
-3.68M

Gaumont Sa 정보

섹터
Motion Pic, Videotape Prodtn
산업
Motion Pic, Videotape Prodtn
웹사이트
본부
Neuilly-sur-seine, Hauts-de-seine, Fra
설립됨
1938
Gaumont Sa is listed in the Motion Pic, Videotape Prodtn sector of the 런던증권거래소 with ticker 0EJB. The last closing price for Gaumont was 135.50 €. Over the last year, Gaumont shares have traded in a share price range of 135.50 € to 135.50 €.

Gaumont currently has 3,120,000 shares in issue. The market capitalisation of Gaumont is 422.76 € million. Gaumont has a price to earnings ratio (PE ratio) of -70.32.

0EJB 최신 뉴스

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 décembre 2024

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 décembre 2024 GAUMONT Informations relatives au nombre total de droits de vote et...

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 30 novembre 2024

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 30 novembre 2024 GAUMONT Informations relatives au nombre total de droits de vote et...

GAUMONT : Rapport financier semestriel au 30 juin 2024

GAUMONT : Rapport financier semestriel au 30 juin 2024 GAUMONT Pièce jointe Rapport financier semestriel au 30 juin 2024

GAUMONT : Communiqué de mise à disposition du rapport financier semestriel au 30 juin 2024

GAUMONT : Communiqué de mise à disposition du rapport financier semestriel au 30 juin 2024   Communiqué de mise à disposition de documents Neuilly-sur-Seine, le 18 septembre 2024 Mise à...

GAUMONT : Résultats semestriels consolidés au 30 juin 2024

GAUMONT : Résultats semestriels consolidés au 30 juin 2024 Communiqué de presse Neuilly-sur-Seine, le 12 septembre 2024 Le Conseil d’administration de Gaumont, réuni le 12 septembre 2024 sous la...

GAUMONT : Information relative au nombre total de droits de vote et d'actions du capital social au 30 juin 2024

GAUMONT : Information relative au nombre total de droits de vote et d'actions du capital social au 30 juin 2024 GAUMONT Informations relatives au nombre total de droits de vote et...

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 mai 2024

GAUMONT : Informations relatives au nombre total de droits de vote et d'actions du capital social au 31 mai 2024 GAUMONT Informations relatives au nombre total de droits de vote et...

GAUMONT : Eligibilité du titre au PEA-PME

GAUMONT : Eligibilité du titre au PEA-PME Communiqué sur l’éligibilité au PEA-PME Neuilly-sur-Seine, le 31 mai 2024 GAUMONT SA confirme son éligibilité au PEA-PME, en respectant, sur la...

GAUMONT : Avis de convocation à l'Assemblée générale mixte du 2 mai 2024

GAUMONT : Avis de convocation à l'Assemblée générale mixte du 2 mai 2024 G A U M O N T Société anonyme au capital de 24 959 384 euros Siège social 30, avenue Charles de Gaulle 92200...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
100135.5135.5135.500DE
400135.5135.5135.500DE
1200135.5135.5135.500DE
2600135.5135.5135.50135.5DE
5200135.5135.5135.50135.5DE
15600135.5135.5135.51135.5DE
26000135.5135.5135.51135.5DE

0EJB - Frequently Asked Questions (FAQ)

What is the current Gaumont share price?
The current share price of Gaumont is 135.50 €
How many Gaumont shares are in issue?
Gaumont has 3,120,000 shares in issue
What is the market cap of Gaumont?
The market capitalisation of Gaumont is EUR 422.76M
What is the 1 year trading range for Gaumont share price?
Gaumont has traded in the range of 135.50 € to 135.50 € during the past year
What is the PE ratio of Gaumont?
The price to earnings ratio of Gaumont is -70.32
What is the cash to sales ratio of Gaumont?
The cash to sales ratio of Gaumont is 1.17
What is the reporting currency for Gaumont?
Gaumont reports financial results in EUR
What is the latest annual turnover for Gaumont?
The latest annual turnover of Gaumont is EUR 221.71M
What is the latest annual profit for Gaumont?
The latest annual profit of Gaumont is EUR -3.68M
What is the registered address of Gaumont?
The registered address for Gaumont is 30 AVENUE CHARLES DE GAULLE, NEUILLY-SUR-SEINE, HAUTS-DE-SEINE, 92200
What is the Gaumont website address?
The website address for Gaumont is www.gaumont.com
Which industry sector does Gaumont operate in?
Gaumont operates in the MOTION PIC, VIDEOTAPE PRODTN sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M
Hardazoak Hardazoak 6 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 6 분 전
KPIFF
wadegarret wadegarret 6 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 6 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 7 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 9 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 9 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 9 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 10 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 11 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 12 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 12 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 13 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 14 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 14 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 17 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 17 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 18 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 19 분 전
Whats 305
RNVA
theorysuit theorysuit 20 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 20 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI

최근 히스토리

Delayed Upgrade Clock